Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Cash from Financing Activities (2016)

Microbot Medical's Cash from Financing Activities history spans 7 years, with the latest figure at $2.2 million for Q4 2016.

  • For the quarter ending Q4 2016, Cash from Financing Activities rose 110.69% year-over-year to $2.2 million, compared with a TTM value of $8.9 million through Dec 2016, up 2052.34%, and an annual FY2025 reading of $86.2 million, up 986.69% over the prior year.
  • Cash from Financing Activities for Q4 2016 was $2.2 million at Microbot Medical, up from $154000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $23.7 million in Q2 2015, with the low at -$20.4 million in Q4 2015.
  • Average Cash from Financing Activities over 5 years is $4.7 million, with a median of $2.3 million recorded in 2012.
  • Biggest YoY gain for Cash from Financing Activities was 3401.89% in 2015; the steepest drop was 1948.54% in 2015.
  • Tracing MBOT's Cash from Financing Activities over 5 years: stood at $5.6 million in 2012, then soared by 199.11% to $16.8 million in 2013, then plummeted by 105.94% to -$995315.0 in 2014, then tumbled by 1948.54% to -$20.4 million in 2015, then soared by 110.69% to $2.2 million in 2016.
  • Per Business Quant, the three most recent readings for MBOT's Cash from Financing Activities are $2.2 million (Q4 2016), $154000.0 (Q3 2016), and $750000.0 (Q2 2016).